Evaluation of the diagnostic value of a three-miRNA panel in prostate cancer: a discovery and validation study

Abstract Background PSA is widely used in prostate cancer screening. However, false-positive PSA results can lead to misdiagnosis and wrong puncture biopsy, while false-negative PSA results can result in missed diagnosis and delayed treatment. There is an urgent need to find convenient, economical a...

Full description

Bibliographic Details
Published in:Discover Oncology
Main Authors: Xutai Li, Chen Sun, Zhenjian Ge, Yingqi Li, Huimei Zhou, Yutong Wu, Shengjie Lin, Pengwu Zhang, Xionghui Wu, Yongqing Lai
Format: Article
Language:English
Published: Springer 2025-04-01
Subjects:
Prostate cancer
MiRNA
PSA
Biomarkers
Bioinformatics
Online Access:https://doi.org/10.1007/s12672-025-02382-w

Internet

https://doi.org/10.1007/s12672-025-02382-w

Similar Items